Market Risers: Anglo Pacific Group, AstraZeneca, Compass Group, Halma plc

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

The stock price for Anglo Pacific Group plc found using EPIC: LON:APF has risen 4.03% or 8 points during today’s session so far. Investors have so far held a positive outlook during the trading session. The period high was 208 and a low of 196.1. The total volume traded so far comes to 168,723 with the daily average number around 193,130. The stock 52 week high is 229 which is 30.5 points difference from the previous days close and the 52 week low at 127 which is a difference of 71.5 points. Anglo Pacific Group plc now has a 20 SMA of 194.18 and the 50 day moving average now at 200.21. The current market cap is £374.74m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Anglo Pacific Group plc being recorded at Tuesday, September 17, 2019 at 12:33:05 PM GMT with the stock price trading at 206.5 GBX.

The trading price for AstraZeneca plc with EPIC code: LON:AZN has moved up 2.21% or 150 points in today’s trading session so far. Investors have stayed positive during this period. The period high was 6952 meanwhile the session low reached 6791.48. The total volume of shares traded by this point was 474,481 whilst the daily average number of shares exchanged is just 2,170,479. The 52 week high for the shares is 7583 which comes in at 790 points difference from the previous days close and the 52 week low at 5312 which is a difference of 1481 points. AstraZeneca plc has a 20 day moving average of 7294.61 and now a 50 day moving average of 7074.12. This puts the market capitalisation now at £91,084.03m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Tuesday, September 17, 2019 at 12:41:47 PM GMT with the stock price trading at 6943 GBX.

Shares in Compass Group plc found using EPIC: LON:CPG has stepped up 2.12% or 41.5 points in today’s trading session so far. Buyers seem confident during the session. The periods high has already touched 2001 dipping to 1951.5. Volume total for shares traded during this period was 618,116 whilst the daily average number of shares exchanged is just 2,571,352. A 52 week share price high is 2150 which comes in at 194.5 points difference from the previous days close and putting the 52 week low at 1467.5 is a variance of 488 points. Compass Group plc has a 20 SMA of 2080.76 with a 50 day moving average of 2046.39. This puts the market cap at £31,672.35m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for Compass Group plc being recorded at Tuesday, September 17, 2019 at 12:40:45 PM GMT with the stock price trading at 1997 GBX.

Shares of Halma plc with company EPIC: LON:HLMA has risen 1.44% or 28 points during today’s session so far. Buyers have remained positive throughout the trading session. The high for the period has peaked at 1982.5 and a low of 1932. The volume total for shares traded up to this point was 135,243 with the daily average traded share volume around 818,219. A 52 week share price high is 2099 around 152.5 points in difference to the previous days close of business and a 52 week low sitting at 1215 a difference of some 731.5 points. Halma plc has a 20 day moving average of 1998.36 and also a 50 day simple moving average now of 1996.89. The market capitalisation currently stands at £7,523.80m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for Halma plc being recorded at Tuesday, September 17, 2019 at 12:41:39 PM GMT with the stock price trading at 1974.5 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Halma plc (LON:HLMA) reports strong half-year results, announcing a 7% interim dividend increase, boosting shareholder returns in 2024.
    Halma Plc acquires Lamidey Noury Medical, expanding its healthcare portfolio with advanced electrosurgical devices for minimally invasive procedures.
    AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.
    AstraZeneca and Amgen's Tezspire shows promise in reducing nasal polyp size and congestion, offering hope for chronic rhinosinusitis patients.
    AstraZeneca's Wainzua gains CHMP backing for EU approval in treating ATTRv-PN, marking a potential breakthrough with self-administered therapy.

      Search

      Search